Stock Market Anomaly | China Biopharmaceuticals (01177.HK) rose more than 3% in early trading. The LM-299 technology transfer has been completed, and they will receive a $300 million milestone payment in the near future.

According to the Zhixin Financial APP, Chinese biopharmaceutical company (01177.HK) surged more than 3% in early trading, as of the time of writing, it increased by 3.19% to 7.7 Hong Kong dollars, with a trading volume of 100 million Hong Kong dollars.